Search research articles
Contact Us
Filters
Showing results (581-590 of 734) with videos related to
Page
of 74
Sort By:
Brain Pathology (Zurich, Switzerland)
|
July 23, 1999
Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines
N Ishii, D Maier, A Merlo, et al.
International Journal of Cancer
|
July 15, 1994
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro
I Desbaillets, M Tada, N de Tribolet, et al.
Clinical Rheumatology
|
August 4, 2007
Chronic myositis with cardiomyopathy and respiratory failure associated with mild form of organ-specific autoimmune diseases
K Tanaka, A Sato, K Kasuga, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
January 1, 1992
Dose-responsive effect of radiotherapy on the tumor uptake of L-[methyl-11C]methionine; feasibility for monitoring recurrence of tumor
K Kubota, K Ishiwata, S Yamada, et al.
Cancer Research
|
October 16, 1999
Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme
M Marutani, H Tonoki, M Tada, et al.
Kokyu to Junkan. Respiration & Circulation
|
August 1, 1982
[Clinical application of prostacyclin to vasospastic angina--releasing effect of PGI2 on coronary artery spasm with intracoronary administration]
Y Koretsune, S Nanto, K Ishikawa, et al.
Oncogene
|
June 29, 2001
Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer
M Naka, T Ozaki, N Takada, et al.
Microbiology and Immunology
|
September 12, 2000
The mechanism of actinomycin D-mediated increase of Borna disease virus (BDV) RNA in cells persistently infected by BDV
T Mizutani, H Inagaki, M Tada, et al.
Biochemical and Biophysical Research Communications
|
June 15, 1995
Plasma nitric oxide end products are increased in the ischemic canine heart
K Node, M Kitakaze, H Kosaka, et al.
Cardiovascular Drugs and Therapy
|
December 1, 1988
The effect of CV-4151, a selective inhibitor of thromboxane synthetase, on prostanoid formation and platelet aggregation in humans
T Kuzuya, Y Kimura, S Hoshida, et al.
Page
of 74
Search research articles
Search
Showing results (581-590 of 734) with videos related to
Sort By:
Page
of 74
Brain Pathology (Zurich, Switzerland)
|
July 23, 1999
Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines
N Ishii, D Maier, A Merlo, et al.
International Journal of Cancer
|
July 15, 1994
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro
I Desbaillets, M Tada, N de Tribolet, et al.
Clinical Rheumatology
|
August 4, 2007
Chronic myositis with cardiomyopathy and respiratory failure associated with mild form of organ-specific autoimmune diseases
K Tanaka, A Sato, K Kasuga, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
January 1, 1992
Dose-responsive effect of radiotherapy on the tumor uptake of L-[methyl-11C]methionine; feasibility for monitoring recurrence of tumor
K Kubota, K Ishiwata, S Yamada, et al.
Cancer Research
|
October 16, 1999
Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme
M Marutani, H Tonoki, M Tada, et al.
Kokyu to Junkan. Respiration & Circulation
|
August 1, 1982
[Clinical application of prostacyclin to vasospastic angina--releasing effect of PGI2 on coronary artery spasm with intracoronary administration]
Y Koretsune, S Nanto, K Ishikawa, et al.
Oncogene
|
June 29, 2001
Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer
M Naka, T Ozaki, N Takada, et al.
Microbiology and Immunology
|
September 12, 2000
The mechanism of actinomycin D-mediated increase of Borna disease virus (BDV) RNA in cells persistently infected by BDV
T Mizutani, H Inagaki, M Tada, et al.
Biochemical and Biophysical Research Communications
|
June 15, 1995
Plasma nitric oxide end products are increased in the ischemic canine heart
K Node, M Kitakaze, H Kosaka, et al.
Cardiovascular Drugs and Therapy
|
December 1, 1988
The effect of CV-4151, a selective inhibitor of thromboxane synthetase, on prostanoid formation and platelet aggregation in humans
T Kuzuya, Y Kimura, S Hoshida, et al.
Page
of 74